Caffeine Completed Phase 3 Trials for BMI >30 kg/m2 Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science3
clinicaltrials.gov IdentifierTitleDrugs
NCT02048215Effect on Energy Metabolism at Cellular Level of Diet Plus Treatment With Ephedrine and Caffeine in Obesity